Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Nuvo Pharmaceuticals Inc., faisant affaire sous le nom de Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (« Miravo » ou la « Société ») et Pharmaceutique Searchlight inc., société privée canadienne...
Les actionnaires de Miravo recevront 1.35 $ par action ordinaire en espèces, ce qui représente une prime de 79.8% par rapport au cours moyen pondéré en fonction du volume sur 90 jours par action...
- Q3 2021 Adjusted Total Revenue - $17.1 million - - Q3 2021 Adjusted EBITDA - $7.0 million - - Blexten Canadian Prescriptions Increased 16% Year-Over-Year - - Cambia Canadian Prescriptions...
Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of...
Miravo Healthcare™ Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference PR Newswire MISSISSAUGA, ON, Sept. 7, 2021 - September 13-15, 2021 (Virtual...
Miravo Healthcare™ Announces Receipt of Health Canada Notice of Compliance for the Pediatric Use of Blexten® PR Newswire MISSISSAUGA, ON, Aug. 12, 2021 - Blexten Label Expanded to...
Miravo Healthcare™ Announces Second Quarter 2021 Results PR Newswire MISSISSAUGA, ON, Aug. 9, 2021 - Q2 2021 Adjusted Total Revenue - $19.9 million -- Q2 2021 Adjusted EBITDA - $7.4 million...
Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea PR Newswire MISSISSAUGA, ON, July 29, 2021 - First Asian Partnering...
Miravo Healthcare™ Announces Second Quarter 2021 Results Release Date and Conference Call Details PR Newswire MISSISSAUGA, ON, July 26, 2021 MISSISSAUGA, ON, July 26, 2021 /PRNewswire/...
Miravo Healthcare™ to Present at Access to Giving Virtual Investor Conference PR Newswire MISSISSAUGA, ON, July 8, 2021 MISSISSAUGA, ON, July 8, 2021 /PRNewswire/ - Nuvo...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.35 | 1.35 | 1.35 | 0 | 0 | CS |
| 4 | 0 | 0 | 1.35 | 1.35 | 1.35 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.35 | 1.35 | 1.35 | 0 | 0 | CS |
| 26 | 0 | 0 | 1.35 | 1.35 | 1.35 | 0 | 0 | CS |
| 52 | 0 | 0 | 1.35 | 1.35 | 1.35 | 0 | 0 | CS |
| 156 | 0.04 | 3.0534351145 | 1.31 | 1.55 | 0.5 | 3665 | 1.1746036 | CS |
| 260 | 0.4 | 42.1052631579 | 0.95 | 2.5 | 0.5 | 6254 | 1.46525909 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
